Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dual Point Acquisition in the Interim Pet Scan Performed During ABVD Treatment, in Early-Stage Hodgkin's Lymphoma Patients With Bulky Lesions

NCT01399931 is registered in ClinicalTrials.gov with Ospedale Santa Croce-Carle Cuneo as lead sponsor.

NCT NCT01399931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01399931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dual Point Acquisition in the Interim Pet Scan Performed During ABVD Treatment, in Early-Stage Hodgkin's Lymphoma Patients With Bulky Lesions
Lead sponsor
Ospedale Santa Croce-Carle Cuneo
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2012
Completion date
January 31, 2017
Enrollment
150 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

hodgkin's lymphoma